Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Genomic Health Company Profile (NASDAQ:GHDX)

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 2 Buy Rating(s)
Consensus Rating:Hold (Score: 2.13)
Consensus Price Target: $30.71 (1.90% downside)

Analysts' Ratings History for Genomic Health (NASDAQ:GHDX)
Show:
DateFirmActionRatingPrice TargetDetailsShare
12/19/2014ZacksReiterated RatingNeutral -> Neutral$33.00ViewTweet This Rating  Share This Rating on StockTwits
12/19/2014Wells Fargo & Co.Initiated CoverageMarket PerformViewTweet This Rating  Share This Rating on StockTwits
12/1/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
11/7/2014Credit SuisseReiterated RatingNeutral$28.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2014Canaccord GenuityReiterated RatingHold$27.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of AmericaReiterated RatingBuy$28.00 -> $30.00ViewTweet This Rating  Share This Rating on StockTwits
10/31/2014TheStreetUpgradeSell -> HoldViewTweet This Rating  Share This Rating on StockTwits
9/24/2014ZacksReiterated RatingNeutral -> Neutral$30.00ViewTweet This Rating  Share This Rating on StockTwits
8/11/2014Canaccord GenuityReiterated RatingHold$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$29.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
3/5/2014TheStreetDowngradeHold -> SellViewTweet This Rating  Share This Rating on StockTwits
2/7/2014Credit SuisseDowngradeOutperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
2/5/2014Bank of AmericaDowngradeUnderperform$30.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
2/5/2014JMP SecuritiesLower Price TargetOutperform$38.00 -> $34.00ViewTweet This Rating  Share This Rating on StockTwits
2/5/2014Jefferies GroupLower Price Target$33.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2013BMO Capital MarketsBoost Price TargetUnderperform$18.00 -> $20.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2013Canaccord GenuityLower Price TargetHold$35.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
11/6/2013William BlairUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
10/1/2013Bank of AmericaDowngradeNeutral -> Underperform$36.00 -> $33.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2013Raymond JamesDowngradeMarket Perform -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
8/2/2013MLV & Co Boost Price TargetHold$30.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
6/25/2013Goldman SachsDowngradeNeutral -> Sell$27.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2013Leerink SwannReiterated RatingOutperform$41.00ViewTweet This Rating  Share This Rating on StockTwits
6/18/2013Bank of AmericaDowngradeBuy -> Neutral$43.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
5/31/2013Jefferies GroupInitiated CoverageHold$35.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013Ladenburg ThalmannBoost Price TargetBuy$36.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
5/10/2013Credit SuisseBoost Price TargetOutperform$37.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2013Canaccord GenuityBoost Price Target$31.00 -> $35.00ViewTweet This Rating  Share This Rating on StockTwits
3/27/2013Leerink SwannUpgradeMarket Perform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/20/2012 forward)